Barrett's esophagus and antireflux surgery: Report of a series of 26 patients;Endobrachyoesophage et chirurgie antireflux: Etude d'une serie de 26 patients

Chirurgie

Volumn 124, Issue 4, 1999, Pages 398-405

  Baulieux, J ^a   Mabrut, J Y ^a   Ducerf, C ^a   Adham, M ^a   De La Roche, E ^a   Berthoux, N ^a   Bourdeix, O ^a   Gaudin, J L ^b   Souquet, J C ^b  

^a Transplantation Unit   (France)

^b CROIX ROUSSE HOSPITAL   (France)

Author keywords

Barrett's esophagus; Endoscopy; Gastroesophageal reflux disease; Laser; Surgery

Indexed keywords

ADULT; AGED; ANTIREFLUX OPERATION; ARGON PLASMA COAGULATION; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LAPAROSCOPIC SURGERY; LAPAROTOMY; MALE; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; CHORISTOMA; EPITHELIUM; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; LAPAROSCOPY; LASER COAGULATION; MIDDLE AGED; PATHOLOGY; STOMACH FUNDOPLICATION; STOMACH MUCOSA; TONGUE DISEASE;

ADULT; AGED; BARRETT ESOPHAGUS; CHORISTOMA; EPITHELIUM; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; FUNDOPLICATION; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; HUMANS; LAPAROSCOPY; LAPAROTOMY; LASER COAGULATION; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TONGUE DISEASES;

EID: 0033198429     PISSN: 00014001     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-4001(00)80012-4     Document Type: Article

References (49)

1. Lortat-Jacob JL. L'endobrachyœsophage. Ann Chir 1957; 11 : 1247-54.
2. Barrett NR. The lower esophagus lined by columnar epithelium. Surgery 1957; 41 : 881-95.
3. Boyer J. Aspects cliniques et endoscopiques de l'endobrachyœsophage. Gastroenterol Clin Biol 1994; 16 : 5-11.
4. Fékété F, Pateron D, Sauvanet A, Kabbej M. La diversion duodénale totale dans le traitement des œsophagites peptiques complexes. Gastroenterol Clin Biol 1997; 21 : 823-31.
5. Paull A, Trier JS, Dalton D, Camp RC, Loeb P, Goyal RK. The histologie spectrum of Barrett's esophagus. N Engl J Med 1976; 295 : 476-80.
6. Potet F. Difficultés de diagnostic de muqueuse de Barrett. Les formes limites d'endobrachyœsophage. Gastroentérol Clin Biol 1994; 18 : 6-13.
7. Hassall E. Barrett's esophagus: Congenital or acquired? Am J Gastroenterol 1993; 88 : 819-24.
8. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar lined (Barrett's) esophagus. N Engl J Med 1985; 313 : 857-9.
9. Gouillat C, Saubier EC. Le cancer sur endobrachy-œsophage. À propos de 16 cas. Ann Chir 1987; 41 : 344-8.
10. Menke-Pluymers MB, Schoute NW, Mulder AH, Hop WC, Dees J, VanBlankenstein M, et al. Outcome of surgical treatment of adenocarcinoma in Barrett's esophagus. Gut 1992; 33 : 1454-8.
11. Michel C, Launoy G, Maurel J, Auvray S, Segol P, Gignoux M. Adénocarcinomes sur endobrachyoesophage. Résultats et facteurs pronostiques à propos de 19 cas opérés. J Chir (Paris) 1992; 129 : 187-90.
12. Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, Demeester TR. Barrett's esophagus: Comparison of benign and malignant cases. Ann Surg 1983; 198 : 554-66.
13. Streitz JM, Ellis FH, Gibb SP, Balogh K, Watkins E. Adenocarcinoma arising in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg 1991; 213 : 122-5.
14. Benchimol D, Myx A, Mouroux J, Baqué P, Bernard JL, Bourgeon A, et al. Adénocarcinome sur endobrachyoesophage. Étude de 28 cas réséqués. Chirurgie 1999; 124 : 141-8.
15. Locke GR, Talley NJ, Carpenter HA, Harmsen WS, Zinsmeister AT, Melton LJ. Changes in the site and histology specific incidence of gastric cancer during a 50 year period. Gastroenterology 1995; 109: 1750-6.
16. Kothari T, Mangla JC, Kalra TMS. Barrett's ulcer and treatment with cimetidine. Arch Intern Med 1980; 140 : 475-77.
17. Sampliner RE, Garewal HS, Fennerty MB, Aickin M. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 1990; 35 : 93-6.
18. Deviere J, Buset M, Dumonceau JM, Rickaert F, Cremer M. Regression of Barrett's epithelium with omeprazole. N Engl J Med 1989; 320 : 1497-8.
19. Galmiche JP, Dumas R, Boyer J, Goldfain D, Bury A, Robaszkiewicz M, et al. Long-term omeprazole effects on Barrett's mucosa. Gastroenterology 1993; 104 : 85.
20. Neumann CS, Iqbal T, Cooper BT. Long-term continuous omeprazole treatment of patients with Barrett's oesophagus. Aliment Pharmacol Ther 1995; 9 : 451-4.
21. Brand DL, Ylvisaker JT, Gelfand M, Pope CE. Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery. N Engl J Med 1980; 302 : 844-8.
22. Radigan LR, Glover JL, Shipley FE, Shoemaker RE. Barrett esophagus. Arch Surg 1977; 112 : 486-91.
23. Burnett HF, Read RC, Morris WD, Campbell GS. Management of complications of fundoplication and Barrett's esophagus. Surgery 1977; 82 : 521-30.
24. Csendes A, Braghetto I, Burdiles P, Puente G, Korn O, Diaz JC, et al. Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: Clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation. Surgery 1998; 126 : 645-57.
25. Demeester TR, Attwood SE, Smyrk TC, Therkildsen DH, Hinder RA. Surgical therapy in Barrett's esophagus. Ann Surg 1990; 212: 528-41.
26. McDonald ML, Trastek VF, Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus: Does an antireflux procedure reduce the need for endoscopic surveillance? J Thorac Cardiovas Surg 1996; 111 : 1135-40.
27. Mangla JC, Schenk EA, Desbaillets L, Guarasci G, Kubasik NP, Turner MD. Pepsin secretion, pepsinogen, and gastrin in «Barrett's esophagus» clinical and morphological characteristics. Gastroenterology 1976; 70 : 669-76.
28. Starnes VA, Adkins RB, Ballinger JF, Sawyers JL. Barrett's esophagus: A surgical entity. Arch Surg 1984; 119 : 563-7.
29. Cheu HW, Grosfeld JL, Heifetz SA, Fitzgerald J, Rescorla F, West K. Persistence of Barrett's esophagus in children after antireflux surgery: Influence on follow-up care. J Fed Surg 1992; 27 : 260-6.
30. Williamson WA, Ellis FH, Gibb SP, Shahian DM, Aretz HT. Effect of antireflux operation on Barrett's mucosa. Ann Thorac Surg 1990; 49 : 537-42.
31. Attwood SEA, Barlow AP, Norris TL, Watson A. Barrett's oesophagus: Effect of antireflux surgery on symptom control and development of complications. Br J Surg 1992; 79 : 1050-3.
32. Sagar PM, Ackroyd R, Hosie KB, Patterson JE, Stoddard CJ, Kingsnorth AN. Regression and progression of Barrett's oesophagus after antireflux surgery. Br J Surg 1995; 82 : 806-10.
33. Ortiz A, Martinez De, Haro LF, Parrilla P, Morales G, Molina J, et al. Conservative treatment versus antireflux surgery in Barrett's oesophagus: Long-term results of a prospective study. Br J Surg 1996; 83 : 274-8.
34. Hamilton SR, Hutcheon DF, Ravich WJ, Cameron JL, Paulson M. Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux. Gastroenterology 1984; 86 : 356-60.
35. Partensky C, Miranda F, Berger F, Moulinier B. Oesophagectomie à thorax fermé pour adénocarcinome sur endobrachyœsophage. Ann Chir 1992; 46 : 303-8.
36. Wright TA, Gray MR, Morris AI, Gilmore IT, Ellis A, Smart HL, et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996; 39 : 574-9.
37. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996; 224 : 66-71.
38. Reid BJ, Weinstein WN, Lewin KL, Haggitt RC, VanDeventer G, Den Besten L, et al. Endoscopic biopsy can detect high grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognisable neoplastic lesion. Gastroenterology 1988; 94 : 81-91.
39. Hameeteman W, Tytgat GNJ, Houthoff HJ, VanDen Tweel JG. Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96 : 1249-56.
40. Potet F, Barge J. La dysplasie dans le tube digestif. Ann Pathol 1991; 11 : 153-61.
41. Fremond L, Bouche O, Diebold D, Demange L, Zeitoun P, Thiefin G. Régression partielle d'un endobrachyœsophage en dysplasic de haut grade avec adénocarcinome après photocoagulation et endocuriethérapie sous traitement antisécrétoire. Gastroenterol Clin Biol 1995; 19 : 112-6.
42. Sampliner RE, Hixson LJ, Fennerty MB, Garewal HS. Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci 1993; 38 : 365-8.
43. Barham CP, Jones RL, Biddlestone LR, Hardwick RH, Shepherd NA, Barr H. Photothermal laser ablation of Barrett's oesophagus: Endoscopic and histological evidence of squamous re-epithelialisation. Gut 1997; 41 : 281-4.
44. Laukka MA, Wang KK, Cameron AJ, Alexander GL. The use of photodynamic therapy in the treatment of Barrett's esophagus [abstract]. Gastroenterology 1993; 104 : 369.
45. Macbride MA, Vanagunas AA, Breshnahan JP, Barch DB. Combined endoscopic thermal electrocoagulation with high dose omeprazole therapy in complicated heterotopic mucosa of the esophagus. Am J Gastroenterol 1995; 90 : 2029-31.
46. Sibille A, Lambert R, Souquet JC, Sabben G, Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995; 108 : 337-44.
47. Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn EG, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998; 114 : 448-55.
48. Maccaughan JS, Nims TA, Guy JT, Hicks WJ, Williams TE, Laufman LR. Photodynamic therapy for esophageal tumors. Arch Surg 1989; 124 : 74-80.
49. Sampliner RE, Jaffe P. Malignant degeneration of Barrett's esophagus: The role of laser ablation and photodynamic therapy. Dis Esophagus 1995; 8 : 104-8.